CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
CB Scientific (OTC PINK:CBSC), a company focused on non-invasive ambulatory cardiac monitoring products, has announced its voluntary delisting from the OTCQB Venture Market. This decision aims to preserve capital for implementing the company's business plan. Importantly, CBSC's common stock will continue trading on the OTC Pink Open Market, allowing shareholders to maintain their ability to trade shares in the public market. The company states that it plans to re-engage an auditor and apply for uplisting when certain milestones are achieved and conditions are appropriate.
CB Scientific (OTC PINK:CBSC), un'azienda specializzata in prodotti per il monitoraggio cardiaco ambulatoriale non invasivo, ha annunciato il suo delisting volontario dal mercato OTCQB Venture. Questa decisione ha lo scopo di preservare il capitale per l'implementazione del piano aziendale. È importante sottolineare che le azioni ordinarie di CBSC continueranno a essere negoziate sul mercato OTC Pink Open, consentendo agli azionisti di mantenere la possibilità di scambiare azioni nel mercato pubblico. L'azienda dichiara che ha intenzione di riassumere un revisore contabile e richiedere la quotazione quando saranno raggiunti determinati traguardi e le condizioni saranno appropriate.
CB Scientific (OTC PINK:CBSC), una empresa centrada en productos de monitoreo cardíaco ambulatorio no invasivos, ha anunciado su deslisting voluntario del mercado OTCQB Venture. Esta decisión tiene como objetivo preservar capital para la implementación del plan de negocios de la empresa. Es importante destacar que las acciones comunes de CBSC continuarán negociándose en el mercado OTC Pink Open, permitiendo a los accionistas mantener su capacidad de comercializar acciones en el mercado público. La empresa declara que planea volver a contratar a un auditor y solicitar la transferencia de listado cuando se logren ciertos hitos y las condiciones sean apropiadas.
CB Scientific (OTC PINK:CBSC)는 비침습적인 외래 심장 모니터링 제품에 주력하는 회사로, OTCQB 벤처 시장에서 자발적으로 상장 폐지를 발표했습니다. 이 결정은 회사의 사업 계획을 구현하기 위한 자본을 보존하기 위한 것입니다. CBSC의 보통주는 OTC Pink Open Market에서 계속 거래될 것이며, 이를 통해 주주들은 공공 시장에서 주식을 거래할 수 있는 능력을 유지하게 됩니다. 이 회사는 특정 이정표가 달성되고 조건이 적절할 때 감사인을 재발탁하고 상장 신청을 할 계획이라고 밝혔습니다.
CB Scientific (OTC PINK:CBSC), une entreprise axée sur des produits de surveillance cardiaque ambulatoire non invasifs, a annoncé son retrait volontaire du marché OTCQB Venture. Cette décision vise à préserver le capital pour la mise en œuvre du plan d'affaires de l'entreprise. Il est important de noter que les actions ordinaires de CBSC continueront à être négociées sur le marché OTC Pink Open, permettant ainsi aux actionnaires de maintenir leur capacité à échanger des actions sur le marché public. L'entreprise déclare avoir l'intention de réengager un auditeur et de demander une mise à niveau lorsque certains jalons seront atteints et que les conditions seront appropriées.
CB Scientific (OTC PINK:CBSC), ein Unternehmen, das sich auf nicht-invasive ambulante Herzüberwachungsprodukte spezialisiert hat, hat seine freiwillige Abmeldung vom OTCQB Venture Market bekannt gegeben. Diese Entscheidung zielt darauf ab, Kapital zur Umsetzung des Geschäftsplans des Unternehmens zu erhalten. Wichtig ist, dass die Stammaktien von CBSC weiterhin am OTC Pink Open Market gehandelt werden, sodass die Aktionäre ihre Möglichkeit behalten, Aktien auf dem öffentlichen Markt zu handeln. Das Unternehmen erklärt, dass es plant, einen Wirtschaftsprüfer wieder zu engagieren und eine Anfrage für ein Upgrade zu stellen, wenn bestimmte Meilensteine erreicht sind und die Bedingungen angemessen sind.
- Continued trading on OTC Pink Open Market, maintaining shareholder liquidity
- Capital preservation for business plan implementation
- Future plans for re-engaging auditor and potential uplisting
- Voluntary delisting from OTCQB Venture Market
- Potential reduction in visibility and investor confidence
- Implied financial constraints necessitating cost-cutting measures
LAS VEGAS, NV / ACCESSWIRE / August 20, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced today that the Company is voluntarily delisting its common stock ("Common Stock") from trading on the OTCQB Venture Market. Delisting from the OTCQB Venture Market will have no impact on Company's Common Shares which will continue to trade on the OTC Pink Open Market providing stockholders the ability to trade their shares in the public market as they can do now.
The decision to delist from the OTCQB Venture Market was made to preserve capital for implementing the company's business plan. As the Company achieves certain milestones, and when conditions are appropriate, it will be prepared to re-engage an auditor and apply to uplist.
About CB Scientific, Inc.
CB Scientific, Inc., through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our electrocardiogram (EKG) devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms provides improved compliance for patients at risk of abnormal heart rhythms, as well as more accurate information for physicians.
Company Contact Information:
Telephone: (888) 225-0870
Email: General Inquiries: info@cbscientificinc.com
Investor Inquiries: investor@cbscientificinc.com
Follow CBSC: X, Facebook, Instagram, LinkedIn, YouTube, and Newsletter
This information disclosure may contain forward-looking statements covered within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions, and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including, without limitation, the ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE: CB Scientific, Inc.
View the original press release on accesswire.com
FAQ
Why is CB Scientific (CBSC) delisting from the OTCQB Venture Market?
Will shareholders of CB Scientific (CBSC) still be able to trade their shares after delisting?
What are CB Scientific's (CBSC) future plans regarding market listing?
When will CB Scientific (CBSC) delist from the OTCQB Venture Market?
